{"id":"W2166077573","doi":"10.1136/annrheumdis-2013-205056","title":"Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":441,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"Genentech; Celgene; Servier; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Apremilast; Medicine; Psoriatic arthritis; Placebo; Leflunomide; Internal medicine; Adverse effect; Psoriasis; Rheumatology; Discontinuation; Rheumatoid arthritis; Dermatology; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001837852,0.0002772344,0.001576529,0.00009541604,0.00007062801,0.00001392625,0.00009456852,0.00004026528,0.00006994974],"category_scores_gemma":[0.0004871477,0.0001506284,0.0003897175,0.0001616778,0.0001682914,0.00009357242,0.00002410044,0.0000380266,0.000003182524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002894988,"about_ca_system_score_gemma":0.0001187161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002096502,"about_ca_topic_score_gemma":0.0001480924,"domain_scores_codex":[0.9980912,0.0002493738,0.0007798673,0.0002413709,0.0003640912,0.0002740477],"domain_scores_gemma":[0.9983684,0.0004315736,0.0004151309,0.0005037693,0.0001100962,0.0001710517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8525697,0.01084653,0.002248425,0.0001454299,0.0009198324,0.00002577927,0.0007605879,0.00002565475,0.00001326099,0.00003991047,0.0001391181,0.1322658],"study_design_scores_gemma":[0.981081,0.01247239,0.002034176,0.001403737,0.0006923804,0.0000124407,0.0002729859,0.0004771072,0.001134185,0.0002080343,0.00006886155,0.000142681],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919879,0.002987274,0.000009648112,0.0003370128,0.0001737535,0.004205425,0.00007809063,0.00001911201,0.000201727],"genre_scores_gemma":[0.9975784,0.001224334,0.0001017586,0.00006720795,0.0000577897,0.0008283179,0.00002337944,0.0000232758,0.00009546484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1321231,"threshold_uncertainty_score":0.6142446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02614847058889899,"score_gpt":0.3121250710539308,"score_spread":0.2859766004650319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}